Pre-treatment of daily teriparatide enhances the increase of bone mineral density in cortical bones by denosumab therapy

Overview of attention for article published in Therapeutics and Clinical Risk Management, April 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (52nd percentile)
Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

patent: 3 patents

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 12 Mendeley

Summary Patents Dimensions citations

So far, Dimensions has found 2 publications that cite this research output.

2

The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.

The first experience of denosumab therapy on patients with Ehlers–Danlos syndrome and osteoporosis: detailed observation of two patients

Article in Modern Rheumatology Case Reports (March 2021)

Calcium and vitamin D supplementation with 3-year denosumab treatment is beneficial to enhance bone mineral density in postmenopausal patients with osteoporosis and rheumatoid arthritis

Article in Therapeutics and Clinical Risk Management (December 2018)